Chemoinformaics analysis of octadeca-6,9,12,15-tetraenoic-acid
Molecular Weight | 204.232 | nRot | 0 |
Heavy Atom Molecular Weight | 196.168 | nRig | 22 |
Exact Molecular Weight | 204.069 | nRing | 4 |
Solubility: LogS | -6.984 | nHRing | 2 |
Solubility: LogP | 8.224 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 16 |
No. of Oxygen atom | 0 | No. of Arom Bond | 17 |
nHA | 2 | APOL | 30.9143 |
nHD | 0 | BPOL | 10.3057 |
QED | 0.38 |
Synth | 4.832 |
Natural Product Likeliness | 3.19 |
NR-PPAR-gamma | 0.242 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.2 |
Pgp-sub | 0 |
HIA | 0.11 |
CACO-2 | -4.987 |
MDCK | 0.00000647 |
BBB | 0.319 |
PPB | 0.987636 |
VDSS | 3.109 |
FU | 0.0191624 |
CYP1A2-inh | 0.032 |
CYP1A2-sub | 0.671 |
CYP2c19-inh | 0.072 |
CYP2c19-sub | 0.985 |
CYP2c9-inh | 0.114 |
CYP2c9-sub | 0.844 |
CYP2d6-inh | 0.075 |
CYP2d6-sub | 0.9 |
CYP3a4-inh | 0.389 |
CYP3a4-sub | 0.647 |
CL | 9.986 |
T12 | 0.013 |
hERG | 0.005 |
Ames | 0.016 |
ROA | 0.259 |
SkinSen | 0.012 |
Carcinogencity | 0.177 |
EI | 0.189 |
Respiratory | 0.974 |
NR-Aromatase | 0.649 |
Antiviral | Yes |
Prediction | 0.624443 |